- Home
- CRDF vs LPAA Comparison
CRDF vs LPAA Comparison
Compare CRDF & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- LPAA
- Stock Information
- Founded
- CRDF 1999
- LPAA 2024
- Country
- CRDF United States
- LPAA United States
- Employees
- CRDF N/A
- LPAA N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- LPAA
- Sector
- CRDF Health Care
- LPAA
- Exchange
- CRDF Nasdaq
- LPAA Nasdaq
- Market Cap
- CRDF 196.2M
- LPAA 296.1M
- IPO Year
- CRDF N/A
- LPAA 2024
- Fundamental
- Price
- CRDF $2.63
- LPAA $10.32
- Analyst Decision
- CRDF Strong Buy
- LPAA
- Analyst Count
- CRDF 4
- LPAA 0
- Target Price
- CRDF $12.00
- LPAA N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- LPAA 35.0K
- Earning Date
- CRDF 05-20-2025
- LPAA 01-01-0001
- Dividend Yield
- CRDF N/A
- LPAA N/A
- EPS Growth
- CRDF N/A
- LPAA N/A
- EPS
- CRDF N/A
- LPAA N/A
- Revenue
- CRDF $683,000.00
- LPAA N/A
- Revenue This Year
- CRDF N/A
- LPAA N/A
- Revenue Next Year
- CRDF N/A
- LPAA N/A
- P/E Ratio
- CRDF N/A
- LPAA $48.18
- Revenue Growth
- CRDF 39.96
- LPAA N/A
- 52 Week Low
- CRDF $2.01
- LPAA $9.66
- 52 Week High
- CRDF $5.64
- LPAA $10.70
- Technical
- Relative Strength Index (RSI)
- CRDF 41.22
- LPAA N/A
- Support Level
- CRDF $2.42
- LPAA N/A
- Resistance Level
- CRDF $2.87
- LPAA N/A
- Average True Range (ATR)
- CRDF 0.18
- LPAA 0.00
- MACD
- CRDF 0.01
- LPAA 0.00
- Stochastic Oscillator
- CRDF 24.42
- LPAA 0.00
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About LPAA Launch One Acquisition Corp. Class A Ordinary shares
Launch One Acquisition Corp is a blank check company.